CDK1-IN-4
Based on 1 publication(s) in Google Scholar
CDK1-IN-4 (10d) is a selective CDK1 inhibitor with IC50s of 44.52, 624.93 and 135.22 nM for CDK1, CDK2 and CDK5, respectively. CDK1-IN4 inhibits the growth of cancer cells by affecting cell cycle. CDK1-IN-4 can be used for the research of cancer.
For research use only. We do not sell to patients.
- CAS No.: 3032997-16-0
- Formula: C26H24ClN5S
- Molecular Weight:474.02
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) CDK1-IN-4
More
Biological Activity
Description
IC50 & Target
|
CDK1 44.52 nM (IC50) |
CDK2 621.93 nM (IC50) |
CDK5 135.22 nM (IC50) |
In Vitro
CDK1-IN-4 (0-10 μM; 24 h) inhibits the growth of PDAC, melanoma, leukemia, colon and breast cancer cells[1]. CDK1-IN-4 (0-1 μM) inhibits CDK1, CDK2 and CDK5 with IC50s of 36.8, 305.17 and 369.37 nM, respectively[1]. CDK1-IN-4 (0-10 μM) inhibits AXL, PTK2B, FGFR, JAK1, IGF1R and BRAF kinases with IC50s of 2488, 8957, 7620, 8541, 4294 and 1156 nM, respectively[1]. CDK1-IN-4 (0.88 μM; 24 h) decreases CDK1 protein level in vitro and affects cell cycle[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:PDAC, melanoma, leukemia, colon and breast cancer cell lines
-
Concentration:0-10 μM
-
Incubation Time:24 hours
-
Result:Inhibited cell growth of PDAC, melanoma, leukemia, colon, and breast cancer cell over 69%, and inhibited MDA-PATC53 and PL45 cells with IC50s of 0.88 and 1.14 μM, respectively.
-
Cell Line:MDA-PATC53 cell line
-
Concentration:0.88 μM
-
Incubation Time:24 hours
-
Result:Downregulated CDK1 protein level compared to untreated cells.
-
Cell Line:MDA-PATC53 cell line
-
Concentration:0.88 μM
-
Incubation Time:24 hours
-
Result:Significantly arrested in G2/M phase of the cell cycle compared with the untreated cells.
Chemical Information
-
CAS No. 3032997-16-0
-
Molecular Weight 474.02
-
Formula C26H24ClN5S
-
SMILES
S=C(N1CCN(C2=NN=C(CC3=CC=CC=C3)C4=C2C=CC=C4)CC1)NC5=CC=CC(Cl)=C5
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
J Exp Clin Cancer Res
Deubiquitylase YOD1 regulates CDK1 stability and drives triple-negative breast cancer tumorigenesis. [Abstract]2023 Sep 4;42(1):228. PMID: 37667382
Protocols
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)